Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
MRVI Maravai LifeSciences
- 2.265
- -0.135-5.63%
Close Mar 21 16:00 ET
- 2.300
- +0.035+1.55%
Post 20:01 ET
325.37MMarket Cap-2.16P/E (TTM)
2.380High2.070Low12.72MVolume2.120Open2.400Pre Close28.50MTurnover12.94%Turnover RatioLossP/E (Static)143.65MShares11.55552wk High1.00P/B222.68MFloat Cap2.07052wk Low--Dividend TTM98.31MShs Float63.550Historical High--Div YieldTTM12.92%Amplitude2.070Historical Low2.240Avg Price1Lot Size
Maravai LifeSciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -94.09%7.47M | -287.91%-14.64M | -7.27%13.14M | -9.17%17.43M | -109.95%-8.47M | -76.45%126.22M | -92.16%7.79M | -87.13%14.17M | -88.32%19.19M | -47.58%85.07M |
| Net income from continuing operations | -87.62%-259.62M | 57.72%-46.5M | -1,065.11%-175.96M | -21.34%-14.49M | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M |
| Operating gains losses | --3.19M | ---- | ---- | ---- | -318.56%-1.92M | ---- | ---- | ---- | ---- | 322.12%878K |
| Depreciation and amortization | 16.57%56.87M | 11.91%14.53M | 7.20%14.04M | 23.30%14.55M | 26.09%13.75M | 28.02%48.78M | 29.42%12.98M | 32.16%13.1M | 32.43%11.8M | 17.84%10.91M |
| Deferred tax | -99.69%2.32M | -99.70%2.32M | --0 | --0 | --0 | 1,672.41%756.24M | 10,308.19%766.04M | -159.91%-5.53M | -121.44%-2.76M | -111.50%-1.52M |
| Other non cash items | 100.26%1.77M | 99.91%-616K | -37.55%1.96M | 88.77%-545K | -47.35%963K | -7,172.47%-672.85M | -15,812.63%-672.97M | 189.30%3.15M | 34.33%-4.85M | 169.65%1.83M |
| Change In working capital | -112.89%-12.61M | -520.93%-10.01M | -32.35%5.8M | -87.92%2.24M | -115.57%-10.64M | 317.04%97.84M | 115.09%2.38M | 186.11%8.57M | 266.71%18.55M | 929.58%68.34M |
| -Change in receivables | -82.99%14.36M | -29.14%-11.35M | 206.41%9.84M | -126.73%-2.02M | -78.30%17.88M | 478.93%84.4M | 65.92%-8.79M | -44.94%3.21M | 6,674.78%7.56M | 3,817.05%82.41M |
| -Change in inventory | -41.91%377K | 114.97%327K | -1.74%-1.52M | -90.26%751K | 124.24%820K | -93.14%649K | -111.33%-2.18M | 35.34%-1.5M | 188.60%7.71M | -381.68%-3.38M |
| -Change in prepaid assets | -75.84%1.97M | -84.38%996K | -87.38%439K | -100.93%-199K | 103.17%730K | 122.66%8.14M | 1,242.11%6.38M | 113.22%3.48M | 269.42%21.29M | -1,014.26%-23.01M |
| -Change in payables and accrued expense | -208.04%-22.03M | -92.08%618K | -155.41%-2.42M | 147.99%7.57M | -215.87%-27.8M | 194.47%20.39M | 185.97%7.81M | -61.93%4.37M | -337.16%-15.77M | 1,235.89%23.99M |
| -Change in other current liabilities | 60.58%-6.3M | 29.88%-1.15M | 72.51%-298K | -40.51%-3.73M | 89.38%-1.13M | -517.29%-15.98M | -178.88%-1.64M | -209.38%-1.08M | -241.92%-2.65M | -856.09%-10.6M |
| -Change in other working capital | -494.40%-986K | -33.17%540K | -359.57%-244K | -132.51%-132K | -8.70%-1.15M | 103.51%250K | 129.54%808K | -75.77%94K | -76.69%406K | 83.77%-1.06M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -94.09%7.47M | -287.91%-14.64M | -7.27%13.14M | -9.17%17.43M | -109.95%-8.47M | -76.45%126.22M | -92.16%7.79M | -87.13%14.17M | -88.32%19.19M | -47.58%85.07M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 80.12%-24.32M | 61.78%-4.93M | 42.27%-8.96M | 74.41%-6.18M | 93.91%-4.24M | 54.30%-122.31M | 30.33%-12.9M | -165.44%-15.52M | -1,354.36%-24.16M | 71.14%-69.73M |
| Net PPE purchase and sale | 57.27%-22.52M | 67.98%-4.13M | 48.72%-7.96M | 74.69%-6.18M | -2,752.50%-4.24M | -229.61%-52.69M | -152.55%-12.9M | -139.99%-15.52M | -1,370.50%-24.43M | 105.82%160K |
| Net intangibles purchase and sale | ---1.5M | ---500K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | 70.79%-69.62M | --0 | --0 | --109K | 70.80%-69.73M |
| Net other investing changes | ---300K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---159K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 80.12%-24.32M | 61.78%-4.93M | 42.27%-8.96M | 74.41%-6.18M | 93.91%-4.24M | 54.30%-122.31M | 30.33%-12.9M | -165.44%-15.52M | -1,354.36%-24.16M | 71.14%-69.73M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -285.84%-235.71M | -50,352.98%-236.19M | 3.32%809K | 100.53%228K | 97.08%-560K | 67.42%-61.09M | 100.71%470K | 102.09%783K | 0.64%-43.13M | 52.60%-19.21M |
| Net issuance payments of debt | -3,955.32%-234.07M | -15,182.29%-229.54M | -2.43%-1.52M | -5.75%-1.51M | -10.66%-1.51M | -6.10%-5.77M | -10.44%-1.5M | -9.12%-1.48M | -4.85%-1.43M | 0.00%-1.36M |
| Proceeds from stock option exercised by employees | -10,310.00%-2.08M | -71.51%-602K | ---- | ---- | ---- | -100.85%-20K | -196.16%-351K | ---- | ---- | ---- |
| Net other financing activities | 100.80%443K | -360.31%-6.05M | 96.75%3.81M | 104.16%1.74M | 105.29%945K | 70.01%-55.3M | 103.57%2.32M | 105.26%1.94M | 2.07%-41.71M | 55.25%-17.85M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -285.84%-235.71M | -50,352.98%-236.19M | 3.32%809K | 100.53%228K | 97.08%-560K | 67.42%-61.09M | 100.71%470K | 102.09%783K | 0.64%-43.13M | 52.60%-19.21M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.04%574.96M | -0.25%578.16M | -1.21%573.17M | -10.60%561.69M | -9.04%574.96M | 14.67%632.14M | -6.13%579.61M | 5.36%580.18M | 45.61%628.27M | 14.67%632.14M |
| Current changes in cash | -341.73%-252.56M | -5,408.46%-255.76M | 973.20%4.99M | 123.87%11.48M | -243.36%-13.27M | -170.70%-57.18M | -131.60%-4.64M | -100.86%-571K | -140.35%-48.1M | 96.77%-3.87M |
| End cash Position | -43.93%322.4M | -43.93%322.4M | -0.25%578.16M | -1.21%573.17M | -10.60%561.69M | -9.04%574.96M | -9.04%574.96M | -6.13%579.61M | 5.36%580.18M | 45.61%628.27M |
| Free cash flow | -139.05%-23.69M | -132.96%-20.99M | 313.43%3.55M | 234.37%7.88M | -118.30%-14.13M | -88.31%60.67M | -109.67%-9.01M | -101.60%-1.66M | -103.61%-5.87M | -51.61%77.21M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.